RADNOR, Pa. -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced the opening of its newest Centralized Service Center (CSC) serving the Greater Boston area. The new facility in Watertown, Massachusetts, addresses the shortage of laboratory space for [...]

AUSTIN, Texas -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) today announced that its Board of Directors has initiated a review of strategic alternatives in order to explore ways to maximize shareholder value. The review will include a range of potential actions, including raising equity capital, reverse mergers, combination transactions, and the sale of [...]

Shimadzu Corporation (head office: Nakagyo-ku, Kyoto; Representative Director, President & CEO Yasunori Yamamoto, hereinafter “Shimadzu”) announced today that it has entered into a strategic partnership agreement (hereinafter “Partnership Agreement”) with Japan Activation Capital, Inc. (Representative Director & CEO Hiroyuki Otsuka, hereinafter “JAC”) to achieve sustainable growth and increase corporate value at Shimadzu. Background to the [...]

As of January 1, 2026, Anton Paar will be represented in Chile with its own subsidiary, expanding the company’s international sales network to a total of 40 subsidiaries worldwide. Anton Paar Chile, headquartered in Santiago de Chile, will be responsible for sales, service, and support in the Chilean market. Santiago, with a population of around [...]

New method enables single cell discovery from archived tissue samples, expanding access to translational and clinical research SEATTLE -- Parse Biosciences, the leading provider of scalable and accessible single cell sequencing solutions, today announced a breakthrough technology that unlocks the full potential of formalin-fixed, paraffin-embedded (FFPE) samples. By enabling whole transcriptome capture from archived tissues [...]

STOCKHOLM -- Pixelgen Technologies today announced the appointment of Dr. Aaron D. Viny, an internationally recognized physician-scientist at Columbia University Irving Medical Center, to its Scientific Advisory Board (SAB). Dr. Viny will help advance the company's science and product development as it expands its commercial footprint for applications in blood diseases and cancer. "Dr. Viny's groundbreaking research into how [...]

First-in-class isogenic model of the human neurovascular unit offers unparalleled human relevance for studying blood-brain barrier drug transport and neuroinflammation. BOSTON -- Emulate, Inc., the leading provider of next-generation Organ-on-a-Chip technology, in partnership with FUJIFILM Cellular Dynamics, Inc., a pioneering global developer and manufacturer of human induced pluripotent stem cells (iPSCs), today announced the launch [...]

New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies from early research to clinical readiness WALTHAM, Mass. -- Thermo Fisher Scientific Inc., the world leader in serving science, today announced the grand opening of its East Coast flagship Advanced Therapies Collaboration Center (ATxCC) in [...]

Initiative led by researchers in Australia and Japan aims to map cancer and immune interactions to advance precision oncology across the region PLEASANTON, Calif. and SYDNEY -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, the Garvan Institute of Medical Research in Australia and the University of Tokyo in Japan, [...]

– Partnership focuses on “kitted” tests in ex-U.S. markets, enabling accelerated access through a decentralized model – – Deal potentially worth $200+ million increases Roche’s investment in Freenome with $75 million equity instrument and R&D support through innovative applications and technology collaboration – Brisbane, CA —Freenome, an early cancer detection company developing blood-based screening tests, today announced [...]